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Background: Cell-free protein synthesis is a rapid and efficient method for the production of recombinant proteins.
Usage of prokaryotic cell-free extracts often leads to non-functional proteins. Eukaryotic counterparts such as wheat
germ extract (WGE) and rabbit reticulocyte lysate (RLL) may improve solubility and promote the correct folding of
eukaryotic multi-domain proteins that are difficult to express in bacteria. However, the preparation of WGEs is
complex and time-consuming, whereas RLLs suffer from low yields. Here we report the development of a novel
cell-free system based on tobacco Bright Yellow 2 (BY-2) cells harvested in the exponential growth phase.
Results: The highly-productive BY-2 lysate (BYL) can be prepared quickly within 4–5 h, compared to 4–5 d for WGE.
The efficiency of the BYL was tested using three model proteins: enhanced yellow fluorescent protein (eYFP) and
two versions of luciferase. The added mRNA was optimized by testing different 5’ and 3’ untranslated regions
(UTRs). The protein yield in batch and dialysis reactions using BYL was much higher than that of a commercial
Promega WGE preparation, achieving a maximum yield of 80 μg/mL of eYFP and 100 μg/mL of luciferase,
compared to only 45 μg/mL of eYFP and 35 μg/mL of luciferase in WGEs. In dialysis reactions, the BYL yielded
about 400 μg/mL eYFP, representing up to 50% more of the target protein than the Promega WGE, and equivalent
to the amount using 5Prime WGE system.
Conclusions: Due to the high yield and the short preparation time the BYL represents a remarkable improvement
over current eukaryotic cell-free systems.
Keywords: Cell-free protein synthesis, In vitro translation, Nicotiana tabacum cv. BY-2, Wheat germ extract,
Protein expressionBackground
Cell-free protein synthesis (CFPS) systems based on crude
lysates provide several advantages over in vivo systems
and offer broad applications in protein engineering, bio-
pharmaceutical product development and post-genomic
research [1]. Crude lysates contain the necessary compo-
nents for translation, protein folding, and energy metabol-
ism, so providing them with amino acids, energy substrates,
nucleotides and salts allows almost any protein encoded
by a RNA template to be synthesized. In coupled tran-
scription/translation systems supplemented additionally
with an appropriate RNA polymerase DNA templates can* Correspondence: matthias.buntru@ime.fraunhofer.de
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unless otherwise stated.also be used. In contrast to traditional cell-based expres-
sion methods, CFPS offers shorter process times, limited
protein hydrolysis and the ability to express toxic proteins
or proteins containing specific chemical groups or unnat-
ural amino acids at defined positions [2]. Furthermore,
the open nature of the system allows the reaction to be
controlled and monitored directly. Although chemical
synthesis allows the rapid and controlled synthesis of
peptides < 40 residues in length, this is not an economically
feasible method for the production of larger proteins [3].
The most widely used cell-free systems are based on
Escherichia coli extract (ECE), wheat germ extract (WGE),
rabbit reticulocytes lysate (RLL) and insect cell extract
(ICE). These contain diverse cellular components and co-
factors that enhance protein expression, folding and modi-
fication in different ways. Therefore, the most appropriateLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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ture of the target protein. The preparation of ECE is sim-
ple and inexpensive, and generally achieves the highest
protein yields, from hundreds of micrograms to milli-
grams per milliliter in batch reactions depending on the
target protein [4,5]. In contrast, eukaryotic systems are
less productive and extract preparation is more laborious,
but complex proteins can be produced more efficiently
and extended post-translational modifications are sup-
ported. WGE normally yields tens of micrograms to milli-
grams of recombinant protein per milliliter, depending on
the protein and reaction format [6-8], but extract prepar-
ation takes 4–5 d, and the yield of extract from wheat
seeds is low [9]. The yields of RLL systems are typically
two orders of magnitude lower than WGE [10] and ICEs
prepared from Spodoptera frugiperda can achieve yields of
up to 50 μg/mL [11]. Recently two further eukaryotic sys-
tems based on CHO cells [12] and Saccharomyces cerevi-
sae [13] have been described. The CHO extract yield up
to 50 μg/mL active firefly luciferase, but the fermentation
medium is quit expensive. In contrast the preparation of
the yeast extract is inexpensive, but the system produces
only low target protein levels of 8 μg/mL active firefly
luciferase. The drawbacks of current cell-free systems
have therefore created a demand for highly-productive
eukaryotic cell-free systems that can be prepared quickly
in large amounts.
Here we describe a highly-productive in vitro translation
system derived from tobacco BY-2 cells. This type of cells
was used due to the eukaryotic nature, the simple and
cost-effective fermentation and the well-established gen-
etic modification tools. The novel system was tested
against commercial WGEs for the production of three
model proteins: enhanced yellow fluorescent protein
(eYFP), firefly luciferase (FFLuc) and Renilla reniformis lu-
ciferase (RRLuc). By measuring the activity of these optical
reporter proteins, the rate of translation was determined
without radioactive substrates. Several different 5’ and 3’
untranslated regions were also compared for their transla-
tion enhancing activity.
Results and discussion
Preparation of the tobacco Bright Yellow-2 lysate (BYL)
At present in vitro translation systems suffer from cer-
tain shortages like laborious extract preparation, low
protein synthesis yields or the inability to support post-
translational modifications [14]. The aim of this study
was to establish a system, allowing the rapid preparation
of lysates for cell-free synthesis of satisfactory recombin-
ant protein yields. For this purpose, we further devel-
oped a system based on BY-2 cell suspension cultures
designed for the replication of plant RNA viruses
[15,16]. In contrast to the original protocol using batch-
cultured cells, we used BY-2 cells growing continuouslyin a stirred-tank fermenter at a constant packed cell vol-
ume of 20% and a doubling time of around 32 h, to ensure
a reproducible supply of homogeneous cell material. We
also replaced the conventional cell wall-digesting enzymes
(Cellulase Onozuka RS, Pectolyase Y-23 and Macerozyme
R-10) with the liquid enzymes Rohament CL, Rohament
PL and Rohapect UF, originally intended for the produc-
tion of fruit juice and extracts. Rohament CL comprises a
cellulase concentrate, Rohament PL is a pectinase concen-
trate, and Rohapect UF contains an enzyme complex
including specialized pectinases and arabanases. This re-
duced the costs for the protoplastation step more than
100-fold. However, the most important step in the lysate
preparation is the removal of the lytic vacuoles (Figure 1).
These contain a great part of undesirable enzymes, includ-
ing proteases and ribonucleases. Lysates prepared without
the evacuolation step show nearly no translation activity
[15]. The vacuoles were removed by centrifugation in a
Percoll gradient using a modified method based on those
described by Komoda et al. [15] and Ishibashi et al. [17].
Due to its low density vacuoles can be separated from the
protoplasts yielding high-density evacuolated protoplasts.
The continuous Percoll layer described in the reports
listed above was replaced with a stepwise density gradient,
and the protoplasts were applied directly onto the Percoll-
free top layer. After centrifugation, the evacuolated proto-
plasts concentrated at the interface between the 40% and
70% Percoll layers (Figure 1a), whereas the separated vac-
uoles floated on the top layer. The purity of the evacuo-
lated protoplasts was verified by microscopy (Figure 1b,c).
The yield of the evacuolation step was ~65%, estimated
using a Neubauer counting chamber. The evacuolated
protoplasts were washed and then disrupted by nitrogen
decompression to protect labile cell components from
oxidation [18]. After the removal of nuclei and non-
disrupted cells, the lysate was incubated with nuclease S7
to destroy endogenous mRNA and to reduce background
translation to a minimum [16]. This step leaves the integ-
rity of the 18S and 28S ribosomal RNAs mainly unaffected
and therefore increases the translation efficiency of ex-
ogenous mRNA substantially [16].
The evacuolation step is comparable to the endosperm
removal step during WGE preparation, and is essential
because the endosperm contains several translation in-
hibitors such as tritin and thionin, as well as nucleases
and proteases [6,9,19]. However, the evacuolation step
takes ~90 min, whereas endosperm removal requires 2–
3 d because embryo particles remaining after the grind-
ing and sieving of wheat seeds must be selected manu-
ally to eliminate those containing larger amounts of
endosperm [9]. Without the preselection of embryo par-
ticles by flotation using toxic organic solvents such as
carbon tetrachloride, the selection process would take
even longer [9].
Figure 1 Preparation of evacuolated tobacco BY-2 protoplasts by Percoll gradient centrifugation. (a) Evacuolated protoplasts are
concentrated at the interface between 40% and 70% Percoll. (b) Representative image of protoplasts before evacuolation (Scale bar = 20 μm).
(c) Representative image of evacuolated protoplasts (Scale bar = 20 μm).
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which again is much faster than the equivalent process
during WGE preparation, i.e. the extraction of the wheat
embryos which takes 5–7 h [9]. Furthermore, the nitrogen
decompression method for protoplast lysis protects labile
components from oxidation, in contrast to the crushing of
embryo particles in a mill/mixer or the disruption of pro-
toplasts using a Dounce homogenizer as described in the
original protocol [15,16]. Figure 2 compares the timelines
for the preparation of BYL and WGE, showing that the
preparation of BYL takes 4–5 h compared to 4–5 days
for the WGE. A 3-L BY-2 cell suspension culture can
yield ~30 mL of BYL with a final protein concentration
of 14.9 ± 0.3 mg/mL [20].
In vitro translation activity of BYL in batch reactions
The performance of BYL compared to commercial WGEs
was investigated by producing the reporter proteins eYFP
and luciferase in both systems and measuring fluores-
cence, which is much faster than standard methods and
does not involve radioactive labeling. Kahn et al. [21] and
Yukawa et al. [22] demonstrated that the fluorescence of
GFP produced in cell-free systems was comparable with
the radioactivity of 35S methionine incorporated during
the translation process, showing that translation yield can
be quantified by fluorescence measurement. Similarly, a
correlation between luciferase activity and the incorpor-
ation of 14C leucine has been demonstrated in WGE, RLL
and ECE [23,24].
To maximize protein expression, we optimized the
mRNA sequence introduced into the BYL translation re-
action. Several mRNA structural characteristics affect
translation efficiency [25] including the untranslatedregions (UTRs) at the 5’ and 3’ ends of the coding se-
quence [26,27]. The structure of the 5’ UTR influences
translational initiation, termination and mRNA stability
[28]. One of the rate-limiting steps in translational initi-
ation is the binding of the mRNA to the 43S pre-initiation
complex [29]. The translational machinery is recruited by
the 5’-cap or translational enhancers in the leader se-
quence [30-33]. To find the optimal UTRs for the BY-2
system, we constructed eight different eYFP expression
constructs with various 5’ and 3’ UTRs (Figure 3). The 5’
UTR in pCITE2a contains an internal ribosomal entry site
(IRES) derived from Encephalomyocarditis virus (EMCV),
which is widely used in eukaryotic host cells and cell-free
extracts [34,35]. The pF3A vector was designed for use
with wheat germ extract and contains sequences from
Barley yellow dwarf virus (BYDV) [36]. The pIX4.0 vector
used with ICEs contains the 5’ UTR from a baculovirus
polyhedrin gene and a synthetic 3’ UTR including a poly
(A) sequence. The polyhedrin promoter achieves the high-
est yields in the ICE system [37-40], but because it is also
compatible with the WGE and RLL systems [38] we as-
sumed it would also be functional in the BYL. The 5’
UTR in the pIVEX1.3 vector includes an ARC-1 sequence
element, which is complementary to an internal 18S
rRNA segment [41] and may promote binding to the 40S
ribosomal subunit [42]. This 18S RNA region is highly
conserved among eukaryotes [43], so we assumed it would
be functional in both the BYL and WGE systems. The To-
bacco mosaic virus (TMV) 5’-UTR (omega sequence) is a
well-known translational enhancer that is included in the
vectors pIVEX_Omega_eYFP-His and pIVEX_GAA_O-
mega_eYFP-His [44-47]. It is functional as an enhancer
not only in tobacco plants, but also in the WGE, RLL and
Figure 2 Flowchart showing the preparation of WGE (top panel) and BYL (bottom panel). WGE (top panel). The endosperm is removed
from wheat seeds and embryo particles are washed extensively to remove translation inhibitors from the endosperm. To obtain the extract, the
washed embryo particles are ground with a mortar under liquid nitrogen or in a Waring blender. BYL (bottom panel). BY-2 cells are cultivated in
a 5-L fermenter, harvested in the exponential growth phase (at least 5 days post-inoculation) and converted into protoplasts. The vacuoles are
separated from the protoplasts by centrifugation over a stepwise Percoll gradient. The resulting evacuolated protoplasts are lysed using the
nitrogen decompression method.
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was improved by adding GAA upstream of the initial
GUA triplet [48]. The pIVEX_GAA_E02 construct con-
tains a synthetic sequence which was selected by its ability
to promote the formation of polysomes in WGEs [49].
The eYFP expression constructs described above were
used as templates to produce capped mRNA in vitro in
the presence of the cap analog m7G[5’]ppp[5’]G. Non-
incorporated nucleotides and cap analogs were removed
by gel filtration, and 2 μg of the purified mRNA was
translated in the BYL and WGE (Promega) systems for
18 h. The optimal reaction conditions were defined by
monitoring eYFP fluorescence using capped GAA_Ome-
ga_eYFP-His mRNA as a template. The highest eYFP
fluorescence was detected in the presence of 1.44 mM
magnesium acetate and 61 mM potassium acetate
(Figure 4a,b). Because the optimal potassium concen-
tration is dependent on the template, each construct
was evaluated in the same manner. The optimum po-
tassium concentration ranged from 61 mM (Figure 3;
constructs 1, 2, 4a, 4b, 6) to 68 mM (Figure 3; con-
structs 3, 5, 7). The influence of the templateconcentration was determined using capped GAA_
Omega_eYFP-His mRNA, and saturation was observed
at ~40 ng/μL (Figure 4c). Polyadenylation sequences are
known to increase translational efficiency and mRNA
stability [50]. So we exchanged the TMV 3’ UTR sequence
in pIVEX1.3_eYFP-His and GAA_Omega_eYFP-His with
the equivalent sequence in pIX4.0_His-eYFP, containing a
synthetic poly(A) sequence, but this exchange actually re-
duced the yield of the target protein (Figure 4d). Similarly,
Sawasaki et al. [48] found that translation in WGE does
not depend on a specific 3’ UTR or a poly(A) sequence,
but rather on the length of the 3’ UTR.
In the WGE system, we used 2.1 mM magnesium ac-
cording to the manufacturer’s instructions. The optimal
concentrations of potassium and mRNA were determined
as described for the BYL system (data not shown). The
highest fluorescence intensities were achieved at potas-
sium concentrations of 103 mM (Figure 3, construct 2),
133 mM (constructs 1, 4a, 4b, 5, 6 and 7) and 163 mM
(construct 3). As for the BYL system, 40 ng/μL of capped
GAA_Omega_eYFP-His mRNA was sufficient. When the
optimal concentrations were used with both systems, BYL
Figure 4 Optimization of reaction conditions in batch mode. Effects on eYFP yield caused by (a) magnesium acetate concentration, (b)
potassium acetate concentration, (c) mRNA concentration, (d) presence (+) or absence (−) of poly(A) sequence. Translation reactions were carried
out using capped GAA_Omega_eYFP-His mRNA as the template at 25°C and 500 rpm for 18 h. The relative fluorescence intensities are shown.
Mean values were calculated from three independent translation experiments.
Figure 3 Schematic representation of different eYFP and luciferase expression constructs with various 5’ and 3’ UTRs. EMCV IRES,
Encephalomyocarditis virus internal ribosomal entry site; BYDV 5’ UTR, Barley yellow dwarf virus 5’ untranslated region; BPH 5’ UTR, Baculovirus
polyhedrin gene 5’ untranslated region; Ω, Tobacco mosaic virus 5’ leader sequence (omega); GAA_Ω, Tobacco mosaic virus 5’ leader sequence
(omega) with GAA as first nucleotide triplet; GAA_E02, synthetic 5’ leader sequence; TMV, Tobacco mosaic virus; 5’ UTR*, repetition of a sequence
complementary to the 18S ribosomal RNA; 3’ UTR*, trailer sequence with synthetic poly(A) signal; FFLuc, firefly luciferase; RRLuc, Renilla
reniformis luciferase.
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Figure 5 Translation of eYFP mRNAs with various 5’ and 3’ UTRs in BYL and WGE systems in batch mode. Reactions were carried out
with 2 μg capped mRNA as the template at 25°C and 500 rpm for 18 h. The amount of fluorescent protein was calculated by comparing with an
eYFP standard curve generated by measuring different eYFP concentrations in BYL translation reactions without the mRNA template. Data
represent the averages and standard deviations of six independent translation experiments.
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all eight constructs (Figure 5). GAA_Omega_eYFP-His
was the most productive construct in both systems,
achieving maximum yields of ~78 ± 9 μg/mL eYFP in the
BYL system and 44 ± 4 μg/mL eYFP in WGE batch reac-
tions, after incubation at 25°C and 500 rpm for 18 h.
Based on our findings the pCITE 5’ UTR is deemed un-
suitable for both the BYL and WGE systems, even though
it has previously been used for the replication of plant
RNA viruses in a similar BY-2 system [16]. This may re-
flect the absence of specific translation factors. As ex-
pected, construct pIVEX1.3_eYFP-His worked well in
both systems, probably due to the strong conservation
of the 18S rRNA sequence among eukaryotes. The lys-
ate batch variations of four different preparations tested
in quadruplicates using capped GAA_Omega_eYFP-His
mRNA as template was ±9% (Additional file 1).
We also compared the expression of luciferase genes
from firefly (FFLuc) and Renilla reniformis (RRLuc) in
the BYL and WGE systems, by exchanging the eYFP se-
quence in pIVEX1.3_eYFP-His for the corresponding lu-
ciferase genes (Figure 3). Again, we used 2 μg of capped
mRNA as a template and the reactions were incubated
at 25°C and 500 rpm for 18 h. The translation of both
the firefly and Renilla luciferase RNAs was 350% higher
than in the WGE, corresponding to more than ~100 μg/ml
of the target protein (Figure 6a,b). These data showed that
the target protein yields were similar with three different
model proteins.
In vitro translation activity of BYL in dialysis reactions
Although the BYL system is highly productive, sustainable
in vitro protein synthesis can only be achieved in dialysis
mode when substrates and energy components arecontinuously supplied across a semi-permeable mem-
brane. Dialysis mode also dilutes potentially inhibitory re-
action byproducts, which contributes to the higher
protein yields. To evaluate the BYL system in dialysis
mode, we used RTS Wheat Germ continuous exchange
cell-free (CECF) devices (5Prime) and compared the BYL
system to the two commercial WGEs from Promega and
5Prime. The reaction mixtures for the BYL and Promega
WGE systems were prepared as described above for batch
mode production. The feeding solutions were used in 20
fold excess and contained the same components as the re-
action mixtures with the exception of lysate, mRNA,
RNase inhibitor and creatine phosphokinase. The reaction
mixture for the 5Prime WGE system was prepared accord-
ing to the manufacturer’s instructions. We restricted the
comparison to those constructs yielding the highest
amounts of eYFP in the batch reactions, i.e. constructs 4a,
4b and 6 (Figure 5). We used 60 ng/μl of m2
7,3’-OG[5’]ppp
[5’]G capped mRNA as the template. For all three con-
structs, the BYL system was substantially more productive
than the Promega WGE system (Figure 7a,b), producing
150% more eYFP when tested with the vectors pIVEX1.3_-
eYFP-His and GAA_Omega_eYFP-His. Surprisingly vector
pIVEX1.3_His-eYFP was largely inactive in the Promega
WGE system, but worked fine in the BYL. The BYL system
was also more productive than the 5Prime WGE system,
yielding ~130% more eYFP when tested with pIVEX1.3_-
His-eYFP and ~150% more eYFP when tested with
pIVEX1.3_eYFP-His. The eYFP yield from vector GAA_O-
mega_eYFP-His was comparable in both systems. For
construct GAA_Omega_eYFP-His in each case 10 μl of
the BYL and WGE translation reactions were analysed by
SDS-PAGE (Figure 7b). Notably, eYFP expression in the
BYL system could be enhanced more than five-fold by
switching from batch production to dialysis mode.
Figure 6 Translation of firefly and Renilla reniformis mRNAs in the BYL and WGE systems. Reactions were carried out with 2 μg capped
mRNA as the template at 25°C and 500 rpm for 18 h. (a) Bar graphs show luciferase activity expressed as relative luciferase units (RLU). Data
represent the averages and standard deviations of six independent translation experiments. (b) Typical result of FFLuc translation in the BYL and
WGE systems, in which 1 μl of reaction mixture was combined with 50 μl luciferase assay buffer: FFLuc standard with 0.1 μg/μl (1),
pIVEX1.3_FFLuc-His in BYL (2), pIVEX1.3_FFLuc-His in WGE (3), no template control in BYL (4), no template control in WGE (5).
Figure 7 Translation of eYFP mRNAs in BYL and WGE systems in dialysis mode. Reactions were carried out with 3 μg capped mRNA as the
template at 25°C and 900 rpm for 18 h and 24 h, respectively. The amount of fluorescent protein (a) was determined by comparison with an
eYFP standard curve generated by measuring different eYFP concentrations in BYL translation reactions without a mRNA template. Data represent
the averages and standard deviations of six independent translation experiments. (b) SDS-PAGE of the BYL and WGE translation reactions. In each
case 10 μl of the translation reactions were loaded on a 4-12% gradient gel. Lane 1: GAA_Omega_eYFP-His in BYL; lane 2: no template control in
BYL; lane 3 GAA_Omega_eYFP-His in 5Prime WGE; lane 4: no template control in 5Prime WGE; lane 5: GAA_Omega_eYFP-His in Promega WGE;
lane 6: no template control in Promega WGE; M: molecular weight marker.
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In summary, the BYL is a promising system with high
translational activity, short preparation time and high
potential for scaling-up. It is likely that the efficiency of
the BYL system can be improved further, e.g. by optimizing
reaction conditions through a factorial design approach
[51]. The BYL system is based on eukaryotic components
and should therefore be suitable for the expression of
eukaryotic proteins, but further studies are required to de-
termine whether the BYL system is capable of carrying
out modifications such as glycosylation and the formation
of disulfide bonds. A coupled transcription/translation




Tobacco cells (Nicotiana tabacum L. cv. Bright Yellow
2, BY-2) were cultivated continuously in a 5-L fermenter
(Type 100e, Applicon Biotechnology, AC Schiedam,
Netherlands) with a 20% packed cell volume at 26°C in
the dark in Murashige-Skoog liquid medium (Murashige
and Skoog Basal Salt Mixture, Duchefa Biochemie, Haar-
lem, Netherlands) supplemented with 3% (w/v) sucrose,
1 mg/L thiamine-HCl, 0.2 mg/L 2,4 dichlorophenoxyace-
tic acid and 100 mg/L myo-inositol.
Preparation of the BY-2 cell lysate
The preparation of lysate from evacuolated BY-2 proto-
plasts was carried out as described by Komoda et al.
[15] and Gursinsky et al. [16] with significant modifica-
tions. Protoplasts were prepared from cells in the expo-
nential growth phase of a continuous fermentation at a
constant packed cell volume of 20% by treating the cells
with 3% (v/v) Rohament CL, 2% (v/v) Rohament PL, and
0.1% (v/v) Rohapect UF (all from AB Enzymes, Darmstadt,
Germany) in 0.37 mM mannitol, 5 mM CaCl2, 12.5 mM
sodium acetate (pH 5.8) for 1.5 h. The resulting proto-
plasts were layered onto a discontinuous Percoll gradient
containing (from bottom to top) 70% (v/v, 3 ml), 40% (v/v,
5 ml), 30% (v/v, 3 ml), 15% (v/v, 3 ml) and 0% (3 ml)
Percoll (GE Healthcare, Munich, Germany) in 0.7 M man-
nitol, 20 mM MgCl2, and 5 mM PIPES-KOH (pH 7.0).
After centrifugation at 12,000 g for 1 h at 25°C in a swing-
ing bucket rotor, evacuolated protoplasts were recovered
from the 40-70% (v/v) Percoll solution interface. The eva-
cuolated protoplasts were suspended in three volumes of
TR buffer (30 mM HEPES-KOH (pH 7.4), 80 mM potas-
sium acetate, 0.5 mM magnesium acetate, 2 mM DTT)
supplemented with one tablet per 50 ml of Complete
EDTA-free Protease Inhibitor Mixture (Roche Diagnostics,
Mannheim, Germany) and disrupted using the nitrogen
decompression method in a cell disruption vessel (Parr
Instrument, Frankfurt, Germany) for 30 min at 10 bar.Nuclei and non-disrupted cells were removed by centrifu-
gation at 500 g for 10 min at 4°C. The supernatant was
supplemented with 0.5 mM CaCl2 and treated with 75 U/ml
nuclease S7 (Roche Diagnostics) for 15 min at 20°C. The
lysate was supplemented with 2 mM EGTA as chelating
agent for the Ca2+ ions to inactivate the nuclease and fro-
zen at −80°C in 1-ml aliquots.
DNA template preparation
Plasmid pIVEX1.3_eYFP-His was kindly provided by
Dr. Stefan Kubick (Fraunhofer Institute for Biomedical
Engineering, Potsdam-Golm, Germany). Plasmid pIVEX_-
GAA_Omega_eYFP-His was prepared by inserting annealed
oligonucleotides 1 and 2 (Additional file 2) containing the
T7 promoter and the TMV 5’ leader sequence (omega)
into pIVEX1.3_eYFP-His using the NspI and NcoI sites.
Plasmid pIVEX_GAA_E02_eYFP-His was prepared by insert-
ing annealed oligonucleotides 3 and 4 (Additional file 2)
containing the T7 promoter and the synthetic 5’ UTR E02
into pIVEX1.3_eYFP-His using the NspI and NcoI sites.
Plasmids pIX4.0_His-eYFP, pIVEX1.3_His-eYFP, pF3A_-
His-eYFP and pCITE2a_His-eYFP were generated by
amplifying the His-eYFP sequence from pIX3.0_His-eYFP
(kindly provided by Dr. Stefan Kubick) using the following
primers (Additional file 2): 5 and 6 for cloning into
pIX4.0_eCFP (kindly provided by Dr. Stefan Kubick), 5
and 7 for cloning into pIVEX1.3_eYFP-His and pF3A
(Promega, Mannheim, Germany), and 5 and 8 for cloning
into pCITELuc (kindly provided by Dr. Sven-Erik Behrens,
Institute of Biochemistry and Biotechnology, Halle/Saale,
Germany). The PCR products were digested with BspHI
and NotI, BspHI and KpnI, and BspHI and XbaI, respect-
ively, and introduced into the NcoI and NotI sites of
pIX4.0_eCFP, the NcoI and KpnI sites of pIVEX1.3_eYFP-
His and pF3A, and the NcoI and XbaI sites of pCITELuc.
Omega_eYFP-His was generated using a two-step PCR
procedure (Sawasaki et al., 2007). In the first step,
eYFP-His was amplified using pIVEX1.3_eYFP-His as a
template and the two gene-specific primers 9 and 10
(Additional file 2). In the second step, the T7 promoter
and omega sequence were fused to eYFP-His using
primers 11 (5’ end of T7 promoter), 12 (3’ end of T7 pro-
moter and omega sequence) and 10 as the previous step.
For vector pIVEX1.3_FFLuc-His, the FFLuc gene was
amplified by PCR using pCITELuc as the template and
primers 17 and 18 (Additional file 2). The product was
digested with NcoI and XhoI and reintroduced into pCI-
TELuc in-frame with the His-tag to generate pCITE2a_F-
FLuc-His. Then the FFLuc-His gene was amplified using
primers 17 and 19 and introduced into the NcoI and KpnI
sites of pIVEX1.3_eYFP-His. The RRLuc gene was ampli-
fied by PCR using pSP_RRLuc (kindly provided by Dr.
Sven-Erik Behrens) as the template and primers 20 and 21
(Additional file 2). The product was digested with NcoI
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TE2a_RRLuc-His. The RRLuc-His sequence was then
amplified using primers 20 and 21 and inserted into the
NcoI and KpnI sites of pIVEX1.3_eYFP-His to generate
pIVEX1.3_RRLuc-His. Plasmids pIVEX1.3_eYFP-His_Poly
(A) and pIVEX_GAA_Omega_eYFP-His_Poly(A) were
generated by amplifying the 3’-UTR from pIX4.0_His-
eYFP by PCR using primers 22 and 23 and inserting the
product into the KpnI and EcoRI sites of pIVEX1.3_eYFP-
His and pIVEX_GAA_Omega_eYFP-His.
In vitro transcription
Capped mRNA was transcribed in vitro in the presence
of the cap analogs m7G[5’]ppp[5’]G or m2
7,3’-OG[5’]ppp
[5’]G (New England Biolabs, Ipswich, MA, USA) using
the T7 High Yield RNA Synthesis Kit (New England
Biolabs) and DNA templates amplified by PCR from the
constructs described above using Phusion Polymerase
(New England Biolabs) and the following primers
(Additional file 2): 10 and 13 for pIVEX1.3_eYFP-His,
pIVEX1.3_His-eYFP, pCITE2a_His-eYFP, pIVEX1.3_F-
FLuc-His and pIVEX1.3_RRLuc-His; 10 and 14 for
pIVEX_GAA_Omega_eYFP-His, pIVEX_GAA_E02_eYFP-
His and pIX4.0_His-eYFP; 10 and 11 for Omega_eYFP-
His, and 15 and 16 for pF3A_His-eYFP. The RNA was
purified using the DyeEx 2.0 Spin Kit (Qiagen, Hilden,
Germany).
In vitro translation
Batch reactions contained 50% (v/v) BYL, 30% (v/v)
modified TR buffer (30 mM HEPES-KOH, pH 7.6,
80 mM potassium acetate, 2 mM DTT), 0.75 mM ATP,
0.1 mM GTP, 25 mM creatine phosphate, 50 μM of each
amino acid, 80 μM spermine and 0.2 mg/mL creatine
phosphokinase (Roche Diagnostics). The magnesium
concentration was adjusted with magnesium acetate to
1.44 mM and the potassium concentration was adjusted
with potassium acetate to 61 mM or 68 mM, according
to the expression construct. Any magnesium and potas-
sium already present in the BY-2 cell extracts was ignored.
The batch translation reactions were carried out at 25°C
and 500 rpm for 18 h in a thermomixer (Eppendorf,
Hamburg, Germany). WGE (Promega) translation reac-
tions were carried out according to the manufacturer’s
instructions.
Dialysis reactions were carried out in RTS 100 Wheat
Germ continuous exchange cell-free (CECF) devices
(5Prime, Hamburg, Germany) using the same mixtures de-
scribed for the batch reactions except that we also added
40 units of murine RNase Inhibitor (New England Bio-
labs). Feeding solutions contained 67.5% (v/v) modified TR
buffer. For the BYL system this was 30 mM HEPES-KOH
(pH 7.6), 90 mM potassium acetate, 2.1 mM magnesium
acetate and 2 mM DTT, supplemented with 0.75 mMATP, 0.1 mM GTP, 25 mM creatine phosphate, 50 μM of
each amino acid and 80 μM spermine. For the Promega
WGE system this was 30 mM HEPES-KOH (pH 7.6),
200 mM potassium acetate, 3.1 mM magnesium acetate
and 7.4 mM DTT, supplemented with 1.2 mM ATP,
0.1 mM GTP, 10 mM creatine phosphate, 80 μM of each
amino acid and 500 μM spermidine. Translation reactions
in dialysis mode were carried out at 25°C and 900 rpm for
18 h in a thermomixer (Eppendorf ). Translation reac-
tions with the RTS 100 Wheat Germ CECF Kit (5Prime)
were carried out according to the manufacturer’s
instructions.Product analysis
The fluorescence signal from eYFP was quantified using
a Synergy HT Multi-Mode Microplate Reader (Biotek,
Bad Friedrichshall, Germany) with 485/20 nm excitation
and 528/20 nm emission filters. The quantity of eYFP
was determined by generating a standard curve based on
different concentrations of eYFP in BYL translation reac-
tions without a mRNA template. The eYFP standard was
produced in a home-made E. coli in vitro translation sys-
tem and purified by immobilized metal-affinity chroma-
tography (IMAC) and size exclusion chromatography
(SEC). The concentration of protein was determined
using a colorimetric assay [20].
Firefly and Renilla luciferase activities were measured
with the Luciferase Assay System (Promega) and a GENios
Pro microplate reader (Tecan, Mainz-Kastel, Germany).
Firefly luciferase purchased from Roche Diagnostics was
used as a standard.Sodium dodecyl sulfate polyacrylamide gel
electrophoresis (SDS-PAGE)
SDS-PAGE was performed using precast NuPAGE 4-12%
polyacrylamide Bis-Tris gels (Life Technologies, Carlsbad,
CA, USA). The gel was stained with Coomassie brilliant
blue R-250. PageRuler Prestained Protein Ladder (Thermo
Scientific, Waltham, MA, USA) was used as molecular
weight marker.Availability of supporting data
The data sets supporting the results of this article are
included within the article and its additional file.Additional files
Additional file 1: Lysate batch variations. The table shows the
comparison of translation activities of four lots of BYL preparations.
Translation reactions were carried out using capped GAA_Omega_eYFP-His
mRNA as the template at 25°C and 500 rpm for 16 h, and fluorescence
intensity was measured. Average and standard deviation were
calculated from four translation experiments.
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